Ombre is a technology company.
Ombre has raised $4.0M across 2 funding rounds.
Ombre has raised $4.0M in total across 2 funding rounds.
Ombre has raised $4.0M in total across 2 funding rounds.
Ombre's investors include Floodgate, Greylock, PivotNorth Capital, Visionaire Ventures, Incisive Ventures.
Ombre is a technology company specializing in personalized microbiome testing and probiotic solutions. It develops microbiome testing kits that enable users to receive tailored probiotic recommendations based on their unique microbiome profiles. Ombre serves health-conscious consumers and individuals interested in optimizing their gut health through personalized nutrition and lifestyle interventions. The company addresses the growing demand for personalized wellness solutions by providing actionable insights into gut microbiome health, helping users improve digestion, immunity, and overall well-being. Ombre has shown momentum by integrating advanced microbiome science with accessible consumer products, positioning itself in the expanding personalized health tech market[4].
Ombre was founded by experts in microbiome science and personalized health, emerging from the increasing recognition of the microbiome's role in human health. The idea originated from the founders’ desire to make microbiome testing accessible and actionable for everyday consumers, moving beyond generic probiotic supplements to data-driven, individualized solutions. Early traction came from developing a user-friendly testing kit and establishing partnerships in the health and wellness sector, which helped validate the product’s efficacy and market fit[4][5].
Ombre rides the wave of personalized health and wellness, a trend driven by advances in biotechnology, data analytics, and consumer demand for tailored health solutions. The timing is favorable due to increased public interest in gut health and the microbiome’s impact on overall wellness. Market forces such as rising healthcare costs and a shift toward preventive care support growth in personalized diagnostics and supplements. Ombre influences the broader ecosystem by pushing microbiome science into mainstream consumer health, encouraging innovation in personalized nutrition and digital health monitoring[4][5].
Looking ahead, Ombre is poised to expand its product offerings and deepen its integration of microbiome data with other health metrics, potentially incorporating AI-driven insights. Trends such as increased consumer health literacy, wearable health tech, and demand for personalized wellness will shape its trajectory. Ombre’s influence may grow as it helps normalize microbiome testing and personalized probiotics as standard components of health management, potentially partnering with healthcare providers and wellness platforms to broaden its reach. This positions Ombre as a key player in the evolving personalized health technology landscape[4][5].
Ombre has raised $4.0M across 2 funding rounds. Most recently, it raised $3.0M Seed in October 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2021 | $3.0M Seed | Floodgate, Greylock, PivotNorth Capital, Visionaire Ventures | |
| May 1, 2018 | $1.0M Seed | Incisive Ventures |